This article was originally published in The Gray Sheet
Appropriations Committee approves $1.1 bil. increase to NIH budget at Sept. 15 mark-up, bringing agency to $28.91 bil. for FY 2005. The Senate version represents an increase over a Sept. 9 House budget earmarking $28.51 bil. for NIH. The Senate bill echoes House recommendations that CMS develop a wheelchair coverage policy "firmly based on a functional standard" of what it means for a patient to be "non-ambulatory," including "beneficiaries who cannot perform their basic acts of daily living, toileting, food preparation and emergency egress." The Senate and House both note the cost-effectiveness of avoiding institutional care or hospitalization. At a Sept. 1 town meeting, CMS had proposed new payment codes to help combat power wheelchair fraud (1"The Gray Sheet" Sept. 6, 2004, p. 15)...
You may also be interested in...
ECRI recommends larger, longer-term studies of Johnson & Johnson/Independence Technology's iBOT 3000 stair-climbing power wheelchair to better determine the device's cost-to-benefit ratio
In a statement submitted to the Senate Finance Committee, Natural Products Association CEO Dan Fabricant suggests two ways of improving compliance with new dietary ingredient notification requirements at negligible expense to the US FDA.
Public Company Edition: Legend Biotech raised $424m in its US public market debut. Also, Pfizer commits up to $500m for equity investments and Allogene capitalizes on ASCO with a $550m offering.